These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16880763)

  • 1. Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations.
    Jones RL; Wise H; Clark R; Whiting RL; Bley KR
    Br J Pharmacol; 2006 Sep; 149(1):110-20. PubMed ID: 16880763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction between relaxations induced via prostanoid EP(4) and IP(1) receptors in pig and rabbit blood vessels.
    Jones RL; Chan K
    Br J Pharmacol; 2001 Sep; 134(2):313-24. PubMed ID: 11564649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists.
    Bley KR; Bhattacharya A; Daniels DV; Gever J; Jahangir A; O'Yang C; Smith S; Srinivasan D; Ford AP; Jett MF
    Br J Pharmacol; 2006 Feb; 147(3):335-45. PubMed ID: 16331286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-benzyl)-phenyl]-amine (RO1138452) is a selective, pseudo-irreversible orthosteric antagonist at the prostacyclin (IP)-receptor expressed by human airway epithelial cells: IP-receptor-mediated inhibition of CXCL9 and CXCL10 release.
    Ayer LM; Wilson SM; Traves SL; Proud D; Giembycz MA
    J Pharmacol Exp Ther; 2008 Feb; 324(2):815-26. PubMed ID: 17962517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent contractile actions of prostanoid EP3-receptor agonists on human isolated pulmonary artery.
    Qian YM; Jones RL; Chan KM; Stock AI; Ho JK
    Br J Pharmacol; 1994 Oct; 113(2):369-74. PubMed ID: 7834185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of prostanoid EP receptors by prostacyclin analogues in rabbit iliac artery: implications for anti-restenotic potential.
    McCormick C; Jones RL; Kennedy S; Wadsworth RM
    Eur J Pharmacol; 2010 Sep; 641(2-3):160-7. PubMed ID: 20450909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial agonism of taprostene at prostanoid IP receptors in vascular preparations from guinea-pig, rat, and mouse.
    Chan KM; Jones RL
    J Cardiovasc Pharmacol; 2004 Jun; 43(6):795-807. PubMed ID: 15167273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
    Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
    Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential actions of the prostacyclin analogues treprostinil and iloprost and the selexipag metabolite, MRE-269 (ACT-333679) in rat small pulmonary arteries and veins.
    Orie NN; Ledwozyw A; Williams DJ; Whittle BJ; Clapp LH
    Prostaglandins Other Lipid Mediat; 2013 Oct; 106():1-7. PubMed ID: 23872196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
    Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
    Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea.
    Jones RL; Peesapati V; Wilson NH
    Br J Pharmacol; 1982 Jul; 76(3):423-38. PubMed ID: 6286023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the prostanoid receptors mediating inhibition of PAF-induced aggregation of guinea-pig eosinophils.
    Teixeira MM; al-Rashed S; Rossi AG; Hellewell PG
    Br J Pharmacol; 1997 May; 121(1):77-82. PubMed ID: 9146890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
    Orie NN; Clapp LH
    Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGE1 and PGE2 modify platelet function through different prostanoid receptors.
    Iyú D; Jüttner M; Glenn JR; White AE; Johnson AJ; Fox SC; Heptinstall S
    Prostaglandins Other Lipid Mediat; 2011 Feb; 94(1-2):9-16. PubMed ID: 21095237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of prostanoid EP₃ and TP receptors in guinea-pig isolated aorta: contractile self-synergism of 11-deoxy-16,16-dimethyl PGE₂.
    Jones RL; Woodward DF
    Br J Pharmacol; 2011 Jan; 162(2):521-31. PubMed ID: 20955363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxant actions of nonprostanoid prostacyclin mimetics on human pulmonary artery.
    Jones RL; Qian YM; Wise H; Wong HN; Lam WL; Chan HW; Yim AP; Ho JK
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):525-35. PubMed ID: 9156364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the agonist activity of prostacyclin analogues on prostanoid EP4 receptors using GW 627368 and taprostene: evidence for species differences.
    Jones RL; Chan KM
    Prostaglandins Leukot Essent Fatty Acids; 2005 Apr; 72(4):289-99. PubMed ID: 15763441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primate vascular responses to octimibate, a non-prostanoid agonist at the prostacyclin receptor.
    Merritt JE; Brown AM; Bund S; Cooper DG; Egan JW; Hallam TJ; Heagerty AM; Hickey DM; Kaumann AJ; Keen M
    Br J Pharmacol; 1991 Jan; 102(1):260-6. PubMed ID: 2043927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.